| [1] Kamb A,Wee S,Lengauer C. Why is Cancer Drug Discovery so Difficult[J]. Nat Rev Drug Discov,2007,6(2):115-120.[2] Orton C G. Width of the Therapeutic Window:What is the Optimal Dose-perfraction for High Dose Rate Cervix Cancer Brachytherapy[J]. Int J Radiat Oncol,1995,31(4):1011-1013.[3] Patton J S,Byron P R. Inhaling Medicines: Delivering Drugs to the Body through the Lungs[J]. Nat Rev Drug Discov,2007,6(1):67-74.[4] Ilbasmis-Tamer S,Degim I T. A Feasible Way to Use Carbon Nanotubes to Deliver Drug Molecules: Transdermal Application[J]. Expert Opin Drug Deliv,2012,9(8):991-999. [5] Vanneman M,Dranoff G. Combining Immunotherapy and Targeted Therapies in Cancer Treatment[J]. Nat Rev Cancer,2012,12(4):237-251. [6] Brouwers J R B J. Advanced and Controlled Drug Delivery Systems in Clinical Disease Management[J]. Pharm World Sci,1996,18(5):153-162.[7] Langer R. Drug Dlivery and Targeting[J]. Nature,1998,392(6679):5-10.[8] Sill T J,von Recum H A. Electrospinning: Applicationsin Drug Delivery and Tissue Engineering[J]. Biomaterials,2008,29(13):1989-2006.[9] Kenawy E R,Bowlin G L,Mansfield K,et al. Release of Tetracycline Hydrochloride from Electrospun Poly(ethylene-co-vinylacetate), Poly(lactic acid), and a Blend[J]. J Control Release,2002,81(1/2):57-64.[10] Liu D,Liu S,Jing X,et al. Necrosis of Cervical Carcinoma by Dichloroacetate Released from Electrospun Polylactide Mats[J]. Biomaterials,2012,33(17):4362-4369.[11] Michelakis E D,Webster L,Mackey J R. Dichloroacetate(DCA) as a Potential Metabolic-targeting Therapy for Cancer[J]. Br J Cancer,2008,99(7):989-994.[12] Stacpoole P W,Kerr D S,Barnes C,et al. Controlled Clinical Trial of Dichloroacetate for Treatment of Congenital Lactic Acidosis in Children[J]. Pediatrics,2006,117(5):1519 1531.[13] Tennant D A,Durn R V,Gottlieb E. Targeting Metabolic Transformation for Cancer Therapy[J]. Nat Rev Cancer,2010,10(4):267-77.[14] Vander Heiden M G. Targeting Cancer Metabolism:a Therapeutic Window Opens[J]. Nat Rev Drug Discov,2011,10(9):671-84.[15] Cairns R A,Harris I S,Mak T W. Regulation of Cancer Cell Metabolism[J]. Nat Rev Cancer,2011,11(2):85-95.[16] Sill T J,von Recum H A. Electrospinning: Applications in Drug Delivery and Tissue Engineering[J]. Biomaterials,2008,29(13):1989-2006. [17] Li D,Xia Y. Electrospinning of Nanofibers:Reinventing the Wheel[J]. Adv Mater,2004,16(14):1151-1170.[18] Xu X,Yang L,Xu X,et al. Ultrafine Medicated Fibers Electrospun from W/O Emulsions[J]. J Control Release,2005,108(1):33-42.[19] Gu B K,Park S J,Kim M S. Fabrication of Sonicated Chitosan Nanofiber Mat with Enlarged Porosity for Use as Hemostatic Materials[J]. Carbohydr Polym,2013,97(1):65-73.[20] Abbas R,Fisher J W. A Physiologically Based Pharmacokinetic Model for Trichloroethylene and Its Metabolites, Chloral Hydrate, Trichloroacetate, Dichloroacetate, Trichloroethanol, and Trichloroethanol Glucuronide in B6C3F1 Mice[J]. Toxicol Appl Pharmacol,1997,147(1):15-30. |
